Paradigm Biopharmaceuticals Ltd. announced that independent Non Executive Director Mr. John Gaffney has resigned, effective immediately. After serving on the Paradigm Board for over 9 years, John is now looking to focus on his other roles. Non-Executive Director Amos Meltzer will assume the role of Chair of the Company's Remuneration and Nomination Committee.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.245 AUD | +4.26% | -9.26% | -42.35% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.35% | 56.76M | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- PAR Stock
- News Paradigm Biopharmaceuticals Limited
- Paradigm Biopharmaceuticals Ltd Announces Resignation of John Gaffney as Independent Non Executive Director, Effective Immediately